PL03.06. Zidesamtinib in TKI-naive Patients with Advanced/Metastatic ROS1+ NSCLC: ARROS-1 Efficacy and Safety Data

Monday, September 14, 2026 9:38 AM to 9:48 AM · 10 min. (Asia/Seoul)

Join the event!

See all the content and easy-to-use features by logging in or registering!